Pulse Biosciences Inc expected to post a loss of 40  cents a share - Earnings Preview

Pulse Biosciences

09/08/2022 03:03

* Pulse Biosciences Inc  PLSE.OQ   PLSE.O  is expected
to show a
rise in quarterly revenue when it reports  results on August
10. 
    * The Hayward California-based  company is expected to
report
revenue of $439.67 thousand, according to the mean estimate from
3 analysts, based on Refinitiv data.  
    * ​Refinitiv's mean analyst estimate for Pulse Biosciences
Inc is
for a loss of 40 cents per share. For the same quarter last
year, the company reported a loss of 58 cents per share.
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Pulse
Biosciences
Inc is $5.5​, above​ its last closing price of $1.76. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2022  -0.52       -0.52      -0.58     Missed  -10.8
 Dec. 31 2022  -0.50       -0.51      -0.52     Missed  -2
 Sep. 30 2021  -0.53       -0.53      -0.48     Beat    10​
 Jun. 30 2021  -0.68       -0.69      -0.58     Beat    16.3
 ​​Mar.        -0.49       -0.49      -0.71     Missed  -43.4
 31 2021                                                
 Dec. 31 2020  -0.45       -0.45      -0.54     Missed  -20​
 Sep. 30 2020  -0.44       -0.44      -0.51     Missed  -15.9
 Jun. 30 2020  -0.50       -0.50      -0.53     Missed  -6
 This summary was machine generated August 9 at 02:03 GMT.  All
figures in US dollars  unless otherwise stated